Elanco Animal Health Quarterly Income Statement
NYSE: ELANHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Elanco Animal Health revenue and earnings
In the quarter ended Jun 30, 2026, Elanco Animal Health generated $1.37 billion in revenue, up 10.2% from the same quarter a year earlier. Net income was $54.0 million (+390.9% year over year), for a net margin of 3.9% versus a median of 0.9% in the prior 5 quarters. Gross margin was 58.3% (up from 57.5%).
Diluted earnings per share came in at $0.11, up from $0.02.
Summary generated from market data by MetaCap's automated system. Methodology
Elanco Animal Health income statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.37B | 1.37B | 1.14B | 1.14B | 1.24B | 1.19B | 1.02B | 1.03B | 1.18B | 1.21B | 1.03B | 1.07B |
| Revenue growth (YoY) | +10.23% | +14.92% | +12.16% | +10.39% | +4.81% | -1.00% | -1.45% | -3.56% | +12.02% | -4.14% | +5.08% | +4.09% |
| Cost of Revenue | 570.00M | 586.00M | 555.00M | 530.00M | 528.00M | 509.00M | 501.00M | 492.00M | 495.00M | 515.00M | 516.00M | 487.00M |
| Gross Profit | 798.00M | 785.00M | 589.00M | 607.00M | 713.00M | 684.00M | 519.00M | 538.00M | 689.00M | 690.00M | 519.00M | 581.00M |
| Research & Development | 92.00M | 97.00M | 93.00M | 89.00M | 92.00M | 94.00M | 81.00M | 87.00M | 89.00M | 87.00M | 79.00M | 86.00M |
| Selling, General & Admin | 449.00M | 381.00M | 338.00M | 351.00M | 400.00M | 341.00M | 300.00M | 323.00M | 354.00M | 337.00M | 292.00M | 313.00M |
| Interest Expense | 59.00M | 57.00M | 80.00M | 52.00M | 48.00M | 40.00M | 46.00M | 58.00M | 65.00M | 66.00M | 67.00M | 72.00M |
| Other Income (Expense) | — | — | — | — | — | — | — | -1.00M | -2.00M | -9.00M | -34.00M | -9.00M |
| Pretax Income | 56.00M | 87.00M | -259.00M | -50.00M | 25.00M | 60.00M | -51.00M | 559.00M | -32.00M | 12.00M | -127.00M | -1.10B |
| Income Tax | 2.00M | 30.00M | 17.00M | -16.00M | 14.00M | -7.00M | -43.00M | 195.00M | 18.00M | -20.00M | 14.00M | -1.00M |
| Net Income | 54.00M | 57.00M | -276.00M | -34.00M | 11.00M | 67.00M | -8.00M | 364.00M | -50.00M | 32.00M | -141.00M | -1.10B |
| Net Income growth (YoY) | +390.91% | -14.93% | — | -109.34% | — | +109.38% | — | — | — | -68.93% | — | — |
| EPS (Basic) | 0.11 | 0.11 | -0.56 | -0.07 | 0.02 | 0.14 | -0.02 | 0.74 | -0.10 | 0.06 | -0.29 | -2.22 |
| EPS (Diluted) | 0.11 | 0.11 | -0.55 | -0.07 | 0.02 | 0.13 | -0.01 | 0.73 | -0.10 | 0.06 | -0.29 | -2.22 |
| Shares Outstanding (Basic) | 499.50M | 497.70M | — | 496.80M | 496.60M | 495.10M | — | 494.30M | 494.20M | 493.20M | — | 492.70M |
| Shares Outstanding (Diluted) | 505.90M | 506.00M | — | 496.80M | 500.10M | 499.10M | — | 497.70M | 494.20M | 496.00M | — | 492.70M |
| Gross Margin | 58.33% | 57.26% | 51.49% | 53.39% | 57.45% | 57.33% | 50.88% | 52.23% | 58.19% | 57.26% | 50.14% | 54.40% |
| Net Margin | 3.95% | 4.16% | -24.13% | -2.99% | 89.00% | 5.62% | -78.00% | 35.34% | -4.22% | 2.66% | -13.62% | -102.62% |
This table shows 12 quarterly periods of Elanco Animal Health's income statement, from Q2 2026 back to Q3 2023, across 17 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow ELAN's reporting calendar. What is a income statement?